Linked Life Data

20386072

Source:http://linkedlifedata.com/resource/pubmed/id/20386072

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2010-4-13
pubmed:abstractText
Lamivudine and interferon have been widely used for the treatment of patients with chronic HBV infection. Serum HBV RNA is detected during lamivudine therapy as a consequence of interrupted reverse transcription and because RNA replicative intermediates are unaffected by the drug. In this study, we aimed to determine the detectability of serum HBV RNA during sequential combination therapy of interferon and lamivudine.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
2040-2058
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
177-84
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B.
pubmed:affiliation
Liver Unit, Cathay General Hospital Medical Center, Taipei, Taiwan.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't